A sugar molecule found mainly in beef and lamb may help explain why heavy red meat eaters face a higher risk of type 2 diabetes, according to preliminary research presented this week at the European Association for the Study of Diabetes annual meeting in Milan.
Researchers led by Dr. Leopold Fezeu of Université Sorbonne Paris Nord tracked N-glycolylneuraminic acid, or Neu5Gc, a sugar that occurs naturally in most mammals but which the human body cannot produce on its own. Using dietary records from 89,953 adults enrolled in France's long-running NutriNet-Santé cohort, the team estimated each participant's Neu5Gc intake and followed them for a median of 7.2 years. During that time, 966 participants developed type 2 diabetes.
A Clear Dose-Response Pattern
Participants in the top fifth of meat-derived Neu5Gc intake — a median of 97 grams of red meat a day for men and 73 grams for women — had a 63% higher risk of developing type 2 diabetes than those in the bottom fifth, who ate almost none. The second-highest intake group carried a 41% higher risk, and the association held after adjusting for age, sex, physical activity, smoking, diet quality and existing health conditions.
The link weakened, but remained statistically significant, after researchers additionally adjusted for body mass index; they calculated that obesity accounted for only about 13% of the association. Notably, Neu5Gc from dairy sources showed no link to diabetes risk at all, suggesting that whatever is driving the pattern is specific to red meat rather than to the sugar molecule in general.
"Our findings support chronic inflammation as a specific mechanism linking red meat consumption with T2D," Fezeu said, as reported by Newsweek. He and his colleagues propose that because the human immune system treats Neu5Gc as foreign, repeated exposure may trigger a low-grade, chronic inflammatory response — sometimes called xenosialitis — that over time impairs the body's ability to regulate blood sugar.
The study carries substantial caveats the researchers themselves flagged. It is observational, meaning it can show an association but cannot prove that Neu5Gc causes diabetes. Intake was estimated from self-reported dietary records rather than measured in blood or tissue, and when the researchers additionally adjusted for participants' total red meat consumption, the Neu5Gc association lost statistical significance — a sign the sugar molecule may not be fully separable, statistically, from red meat intake more broadly, and that other components of red meat, such as heme iron, could also be contributing. The results have not yet been published in a peer-reviewed journal and were presented only as a conference abstract, meaning the numbers could shift before a final paper appears.
Outside researchers urged caution for the same reasons. Dr. Flora Bailey, a London-based general practitioner and metabolic health specialist who was not involved in the work, called the findings "interesting" but said "the study is in its early stages, and for me the real value is that it gives researchers another avenue to explore," rather than a reason to change dietary advice immediately.
Fezeu said the next step is to test directly whether reducing intake of Neu5Gc-rich foods like beef and lamb lowers diabetes risk — a trial that would move the finding from correlation toward evidence of cause and effect. Until then, the result adds a specific proposed biological mechanism to a body of existing nutrition research that has already linked high red meat consumption to elevated diabetes risk.
